source_name
MDA-MB-231
cell line
MDA-MB-231
cell type
Breast cancer cells
genotype
WT
treatment
When MDA-MB-231 cells were released from G1/S phase, 1 ug/ml nocodazole was added, and after 10 hr, they were supplemented with 5 ug/ml actinomycin D.
time
with Actinomycin D for 1.5h